ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

OTO PROKOP M.D.

46 FAIRVIEW AVE SUITE 111

Skowhegan | Maine | 04976

(207) 474-0905

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,619Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 247

$606K Total Retail Price of All Prescriptions

Rank: 24 out of 247

353 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 353 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,297 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
FUROSEMIDE 406 324 1 5
LISINOPRIL 381 312 2 2
SIMVASTATIN 357 259 3 1
OMEPRAZOLE 354 261 4 4
LEVOTHYROXINE SODIUM 304 252 5 3
ATENOLOL 273 198 6 10
METOPROLOL TARTRATE 270 236 7 7
HYDROCHLOROTHIAZIDE 206 184 8 9
WARFARIN SODIUM 181 126 9 13
RANITIDINE HCL 181 143 9 34
AMLODIPINE BESYLATE 178 156 11 6
PAROXETINE HCL 160 137 12 45
FLUTICASONE PROPIONATE 159 126 13 37
ATORVASTATIN CALCIUM 156 121 14 8
METFORMIN HCL 156 103 14 12
PRAVASTATIN SODIUM 154 144 16 23
SPIRIVA 132 98 17 26
POTASSIUM CHLORIDE 131 114 18 36
TAMSULOSIN HCL 128 98 19 31
TRAZODONE HCL 127 98 20 28
PANTOPRAZOLE SODIUM 104 95 21 19
ADVAIR DISKUS 101 89 22 18
HUMALOG 94 50 23 78
CLONIDINE HCL 92 58 24 101
ALLOPURINOL 88 75 25 33
LANTUS 86 37 26 39
FINASTERIDE 78 54 27 73
VENLAFAXINE HCL ER 78 36 27 64
LABETALOL HCL 77 54 29 190
SPIRONOLACTONE 76 43 30 53
LANTUS SOLOSTAR 76 49 30 88
JANUVIA 74 55 32 56
PREDNISONE 66 56 33 21
TRIAMTERENE-HCTZ 65 62 34 67
POLYETHYLENE GLYCOL 3350 63 51 35 77
FENOFIBRATE 63 15 35 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 60 37 51
CLOPIDOGREL 62 27 37 70
CARVEDILOL 61 53 39 59
LOVASTATIN 59 59 40 22
NEXIUM 58 41 41 42
CRESTOR 58 12 41 30
LOSARTAN POTASSIUM 57 46 43 15
INSULIN SYRINGE 56 36 44 68
METOPROLOL SUCCINATE 56 51 44 14
GEMFIBROZIL 55 34 46 126
ROPINIROLE HCL 55 46 46 69
SERTRALINE HCL 54 42 48 16
PROAIR HFA 53 33 49 29
TRAMADOL HCL 53 52 49 25
LIDODERM 52 49 51 74
PEN NEEDLE 51 35 52 79
ISOSORBIDE MONONITRATE ER 51 45 52 40
CYCLOBENZAPRINE HCL 51 21 R 52 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.